AstraZeneca India receives permission from CDSCO for Datopotamab Deruxtecan powder
The receipt of this permission paves way for the marketing of Datopotamab Deruxtecan powder for concentrate for solution for infusion 100 mg (r-DNA origin) in India
The receipt of this permission paves way for the marketing of Datopotamab Deruxtecan powder for concentrate for solution for infusion 100 mg (r-DNA origin) in India
The new powder formulation gives children and adults living with Rett syndrome greater flexibility and choice in dose volume and taste
Sodium Zirconium Cyclosilicate powder for oral suspension 5g (Lokelma) is indicated for the treatment of hyperkalaemia in adult patients
Trastuzumab Deruxtecan 100mg/5mL vial lyophilized powder for concentrate for solution for infusion is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors
Shelcal Total marks the brand’s evolution into a modern, consumer-focused nutrition portfolio
New solvent-free micronization technology expanded at the Darmstadt site in Germany
The newly issued patent, US Patent No. 11,957,647, provides both expanded scope of protection as well as longer patent term
With the establishment of five different precious metals alloy powder production methods
Lupin actively contributes to alleviating the burden of COPD for patients across the nation
Tiotropium (as bromide monohydrate) 18 micrograms powder for inhalation in capsule
Subscribe To Our Newsletter & Stay Updated